Endovia Health Sciences, Inc.
EDVA- Exchange
- NYSE
- Industry
- Beverages
- SEC CIK
- 0001553788
No open-market purchases or sales by Endovia Health Sciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $172.1K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Endovia Health Sciences, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 11 | 12 | +1 |
| Shares | 66.7K | 69.4K | +2.67K (+4.0%) |
| Value | $93.4K | $260.9K | +$167.5K (+179.3%) |
New holders (4)
Institutions that held Endovia Health Sciences, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Qube Research & Technologies Ltd | 12,300 | $46.2K | 0.00% |
| UBS Group AG | 2,093 | $7.87K | 0.00% |
| Raymond James Financial Inc | 61 | $229 | 0.00% |
| Delos Wealth Advisors, LLC | 16 | $61 | 0.00% |
Sold out (3)
Institutions that held Endovia Health Sciences, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Tower Research Capital LLC (TRC) | 957 | $1.34K |
| Mather Group, LLC. | 111 | $155 |
| JPMorgan Chase & Co | 3 | $4 |